# Suboxone vs Subutex: The Real Differences, Explained

> Suboxone vs Subutex: one adds naloxone, one does not. Compare ingredients, induction timing, side effects from the FDA labels, and who each medication suits.

URL: https://foundationmedicalgroup.org/suboxone-vs-subutex/
Published: 2026-09-08
Updated: 2026-09-08

Suboxone and Subutex both deliver buprenorphine, the partial opioid agonist that treats opioid dependence. The key difference is a second ingredient. Suboxone adds naloxone, an opioid antagonist that discourages injection. Subutex is buprenorphine on its own, and the FDA label calls plain buprenorphine preferred for induction.
That’s the short version. In our experience most of the worry is about the first day rather than the brand name. The longer one matters, because the choice changes how your first day of treatment goes and how the pharmacy fills your script. Here’s what the labels and the trial data say.
What is in each medication? Buprenorphine binds tightly to the opioid receptor and turns it partway on. That partial action eases opioid withdrawal and quiets opioid cravings without the full effect of heroin or oxycodone. It is the active ingredient in both products.
Naloxone is different. It is an opioid blocker with almost no effect when taken under the tongue, because the body absorbs very little of it by that route. Inject it, though, and it can throw a person who depends on a full opioid agonist straight into withdrawal. The naloxone component is a deterrent against misuse, not part of the treatment.
Feature Suboxone Subutex and generic buprenorphine Active ingredient Buprenorphine plus naloxone Buprenorphine only Common form today Sublingual film in 4 strengths Sublingual tablet, 2 mg and 8 mg First dose after last opioid Not less than 6 hours Not less than 4 hours Label wording on induction Use the sublingual route to limit naloxone exposure Preferred for induction Preferred coming off methadone No, monotherapy is recommended first Yes Brand marketing status at FDA Film marketed, tablets discontinued Brand discontinued, generics available We compared the two labels line by line to build that table. The wording differences in the last three rows are the ones that change a treatment plan.
Suboxone vs Subutex: which one is stronger? Neither. An 8 mg tablet of buprenorphine and an 8 mg/2 mg dose of Suboxone carry the same amount of the working medicine. Dose is measured by the buprenorphine, and the naloxone number simply rides along at a quarter of it.
The trial evidence backs that up. In a 4 week study reported in the Suboxone label, 107 patients took 16 mg/4 mg Suboxone tablets, 103 took 16 mg Subutex tablets, and 107 took placebo. Headache showed up in 36.4 percent of the Suboxone group, 29.1 percent of the Subutex group, and 22.4 percent of placebo. Withdrawal syndrome ran the other way: 25.2 percent on Suboxone, 18.4 percent on Subutex, and 37.4 percent on placebo.
Insomnia was more common on Subutex, at 21.4 percent against 14.0 percent. Constipation was more common on Suboxone, at 12.1 percent against 7.8 percent. Those gaps are small. The label sums it up plainly: “adverse event profiles were similar” for subjects on 16 mg/4 mg Suboxone tablets or 16 mg Subutex tablets. Neither is the gentler option on side effects alone.
When does a doctor choose buprenorphine on its own? Three situations come up most often in addiction medicine.
Induction. The buprenorphine sublingual tablet label states it is preferred for induction, and permits the first dose as soon as 4 hours after the last opioid, once clear signs of moderate opioid withdrawal appear. Coming off methadone or another long acting opioid. The Suboxone label recommends buprenorphine monotherapy here, because the small amount of absorbed naloxone could cause worse and longer precipitated withdrawal. A reaction to the naloxone component. Some patients report headache or nausea that settles when they switch. This is uncommon, and it is worth discussing rather than stopping treatment. Pregnancy is handled case by case with an obstetric team. Ask your prescriber. Don’t read a rule into any of the above.
After induction, most patients move to the combination for maintenance. The Suboxone label puts the usual maintenance range at 4 mg/1 mg to 24 mg/6 mg per day, after a target dose of 16 mg/4 mg.
What does the first week look like? The first week feels much the same on either medicine. You come in when withdrawal has started, not before. The clinic checks your signs. You take a small dose and wait a couple of hours.
If you feel steadier, you take a bit more. Day 1 usually tops out near 8 mg of buprenorphine. Day 2 can go up to 16 mg. From day 3 the dose moves in small steps until the opioid cravings stay quiet all day.
Both forms melt under the tongue over a few minutes rather than being swallowed. Don’t chew either one, and don’t drink for a few minutes after. That’s the whole trick to getting a full dose, and it’s the step patients most often get wrong in week one.
By the end of the week most patients know which product they prefer. Hearing that a switch is allowed is a relief to people who assumed they were stuck. Tell your prescriber. Switching between the tablet and the film is a small change, not a restart.
So which one will you actually be handed? That depends on the pharmacy, the plan, and the day.
And that irritates patients who have spent a week researching the difference. But the buprenorphine is the buprenorphine. The film and the tablet are two envelopes carrying the same letter.
Does one have more abuse potential? Yes, and that is the whole reason the combination exists. Tablets of plain buprenorphine can be crushed and injected. Adding naloxone makes that route unpleasant for someone with a full opioid in their system, which cuts the street value of the medication.
Sublingual use is a different story. Very little naloxone crosses into the blood under the tongue, so a patient taking Suboxone as directed feels the buprenorphine and not the blocker. The Suboxone label notes that buccal dosing raises naloxone exposure slightly, which is why the sublingual route is recommended during induction.
Neither product is a good painkiller, and neither belongs to anyone without a prescription. The buprenorphine tablet label reports deaths in opioid naive people after a single 2 mg sublingual dose. Opioid drugs of any kind deserve that respect.
What happened to the Subutex brand? FDA records show both Subutex tablet strengths, 2 mg and 8 mg, listed as discontinued, along with a Federal Register determination that the product was not withdrawn for safety or effectiveness reasons. The original Suboxone tablets are discontinued too. Suboxone sublingual film remains a marketed prescription medication.
In practice, when your pharmacist hands you “Subutex,” you are getting generic buprenorphine sublingual tablets from one of many manufacturers. The wording on the bottle changes; the medicine does not. Our page on Subutex doctors near you explains how prescribing works day to day.
Access changed as well. SAMHSA notes that the DATA 2000 waiver requirement was removed in December 2022, so any prescriber with a standard DEA registration can now treat opioid use disorder with buprenorphine. That single change did more for opioid addiction treatment than any argument about brands.
Insurance is the other thing that decides what lands in your hand. Some plans favor the film, some favor the generic tablet, and some cover only one strength without a prior authorization. Ask the pharmacy to run both before you leave the clinic. A five minute phone call at the counter saves a week of frustrating back and forth later.
Here’s the thing patients rarely hear said out loud. The brand argument matters far less than whether you keep showing up.
Patients sometimes switch products more than once hunting for the one that fixes it all, when the variable worth changing was the counseling schedule. Which is frustrating to watch, and simple enough to prevent. Ask about the whole plan, not only the pill.
Which is right for you? Start with the clinical question rather than the brand. Are you starting treatment today, or are you stable and looking at maintenance? Are you coming off a short acting opioid or off methadone? Does your insurance cover the film, the tablet, or both?
A prescriber weighs your opioid use history, your risk of injection misuse, your other medications, and cost. Our patients ask about the brand far more often than about the dose, and the dose is the part that matters. It isn’t a brand loyalty question. Most patients in medication assisted treatment do well on either one. If you want to understand the medicine itself before that conversation, our guide to what buprenorphine is covers it without jargon.
Frequently Asked Questions What is the key difference between Suboxone and Subutex? Suboxone contains buprenorphine plus naloxone. Subutex contains buprenorphine only. Both deliver the same partial opioid agonist that treats opioid dependence, and the naloxone component exists to discourage injection, not to add treatment benefit.
Is Subutex stronger than Suboxone? No. An 8 mg Subutex tablet and an 8 mg/2 mg Suboxone dose deliver the same amount of buprenorphine. In a 4 week head to head study, side effect profiles were similar for 16 mg Subutex and 16 mg/4 mg Suboxone.
Why would a doctor prescribe Subutex instead of Suboxone? Buprenorphine on its own is preferred for induction and for patients coming off methadone or another long acting opioid, because the naloxone in the combination can worsen precipitated withdrawal. Some patients also react to the naloxone component.
Is Subutex still available in the United States? The Subutex brand is discontinued according to FDA records, and so are the original Suboxone tablets. Generic buprenorphine sublingual tablets remain widely available, and Suboxone sublingual film is still marketed.
Does Subutex have more abuse potential than Suboxone? It carries more risk of injection misuse, which is why the naloxone version exists. Very little naloxone is absorbed under the tongue, but injecting the combination can push a dependent person into opioid withdrawal.
Key Takeaways and Next Steps Suboxone is buprenorphine plus naloxone; Subutex and generic buprenorphine are buprenorphine only. Milligram for milligram of buprenorphine, they are equally strong. Plain buprenorphine is preferred for induction and for patients leaving methadone. The 4 week head to head study found similar adverse event profiles for both. The Subutex brand is discontinued at FDA, while generic sublingual tablets stay on pharmacy shelves. If you are weighing opioid dependence treatment options, we would be glad to talk it through. Foundation Medical Group prescribes buprenorphine for opioid use disorder in Richmond, Virginia, American Fork, Utah, Decatur, Georgia, and Dallas, Texas. One appointment turns a confusing brand question into a plan you can follow. You don’t have to figure this out alone.
Sources Suboxone (buprenorphine and naloxone) sublingual film prescribing information, DailyMed, National Library of Medicine. Buprenorphine sublingual tablet prescribing information, DailyMed, revised October 2025. Drugs@FDA record for Subutex, NDA 020732, U.S. Food and Drug Administration. Buprenorphine and Naloxone, StatPearls, NCBI Bookshelf. Substance Abuse and Mental Health Services Administration, Waiver Elimination (MAT Act).